Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine in treatment of major depression
IRCT201502161556N72Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of memantine in major depressive disorder (MDD), sponsored by Tehran University of Medical Sciences. Started Jan 2016; status: completed.
02
Drugs
memantine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT201502161556N72.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201502161556N72.